Source: American Banking and Market News

Intellia: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by XTX Topco Ltd

XTX Topco Ltd lifted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 194.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 43,908 shares of the company's stock after acquiring an additional 29,006 shares during the period. XTX Topco Ltd's holdings in Intellia Therapeutics were worth $512,000 as of [...]

Read full article »
Annual Revenue
$25-100M
Employees
250-500
John Leonard's photo - President & CEO of Intellia

President & CEO

John Leonard

CEO Approval Rating

82/100

Read more